Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Elan to produce reformulated Panzem for EntreMed oncology program

July 16, 2004

Fourth phase II study of PI-88 launches

July 16, 2004

Encouraging results for MF-5232 for mucositis

July 16, 2004

Potent uPA inhibitor selected for clinical evaluation at Pfizer

July 16, 2004

Imiquimod in the treatment of AIN in HIV-infected men

July 16, 2004

Silicon compounds for the treatment of cancer reported by Amedis

July 15, 2004

Inhibitors of kinases claimed by Schering AG

July 15, 2004

Novel CDK inhibitors from BMS show in vivo anticancer activity

July 15, 2004

Oxford GlycoSciences claims antiangiogenic agents

July 14, 2004

Vertex claims protein kinase inhibitors

July 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...